Inefficiencies in pharmaceutical supply chain cost. Leveraging AI in drug supply chain management

Dorota Owczarek - March 30, 2021

Supply chain companies are adopting artificial intelligence at a great pace. Many companies are already on their way towards digital transformation across various industries that face supply chain management challenges. The AI applications in supply chain management include, among a host of other uses, process robotization, forecast demand, real-time visibility on shipments, and improved efficiencies in last-mile deliveries. According to Gartner’s report, the use of artificial intelligence (AI) and machine learning was one of the top 2020 trends in supply chain businesses and one of the top technologies giving companies a leg up over the competition.

The pharmaceutical industry is no different. Companies in various ways are applying AI in pharma to gain a competitive advantage. Slowly but steadily, the pharma sector is also becoming the next testing ground for companies looking to use AI to help digitalize and boost their global supply chains.

How is the pharma supply chain different from the classic model? What specific challenges do pharma companies face within supply chain management? And finally, how can AI be used in the supply chain to bring value and return on investment? This article gives an overview on the subject together with dedicated advice on how to implement AI process-wise.

How does the pharma supply chain work?

The pharmaceutical supply chain involves a complex network of steps required to produce a drug, from sourcing and supply of materials, warehousing, through manufacturing and distribution, to the drugs' end delivery to the pharmacy and patient.

pharmaceutical supply chain visibility

Major challenges in the pharmaceutical supply chain

For Big Data transformation in the pharma supply chain to succeed, organizations must transform to overcome the difficulties they face in an ever-changing technological environment.

Pharma’s biggest data challenge is its historical siloed structure resulting from decades-old legacy systems. These disparate data silos prevent access to drug manufacturers' and distributors' data in real-time. It is essential going forward that organizations strive for a data-centric and user-centric approach allowing visibility of the complete data across all channels - the right information at the right time in the right place.

As the operations are struggling to move forward, the drug discovery phase embraces new technologies like no other. The spectacular discoveries and a new wave of therapies based on complex biologic medicines and gene and cell therapies are becoming increasingly popular. Nevertheless, they throw up huge challenges for manufacturing and distribution networks due to their sensitivity, the need for temperature control and special handling, and short life cycle.

The biggest challenges pharmaceutical within the supply chain management include:

  • lack of end-to-end visibility
  • malfunctions at the manufacturing level
  • tight deadlines and costly expedites
  • fragmented multimodal networks
  • cold chain - temperature control and strict handling along the whole process
  • issues related to drug counterfeiting
  • keeping highest quality and repeatability of drug manufacturing
  • personalized treatment production for individual patients (e.g., T-cell therapies)

How AI in the drug supply chain can make a difference?

Artificial Intelligence presents the pharmaceutical industry with the opportunity to solve problems previously unsolvable with simple data analysis. Looking at the pharmaceutical supply chain specifically, we’re seeing a growing number of AI-based solutions offering answers to many of the industry’s current challenges. As organizations look to improve their operational performance, productivity, efficiency, and cost-effectiveness leveraging artificial intelligence across the entire pharmaceutical supply chain seems to be the next move. What are the major benefits AI can bring to the drug supply chain?

Process visibility

artificial intelligence for pharma supply chain visibility

To compressively and accurately assess today’s complex supply chains, a 360-degree approach must be taken. Point-to-point visibility across the whole supply chain will enable companies to become more efficient by rapidly responding to and mitigating disruptions. AI solutions applied to the supply chain can provide an insightful and comparable benchmarking of pharmaceutical supply chains. As artificial intelligence relies heavily on data, a crucial first step must be considered to even think about AI solutions - digital transformation. Information flowing along the supply chain needs to be collected and normalized in real-time. Digitalization is crucial for visibility, and it should be organized with the future AI implementation already in mind. Full visibility means coupled with AI for insights will reveal supply chain performance gaps, e.g., caused by low inventory enabled by low utilization and high unit cost, with a full profile of contextual information. Once this is in place, AI-augmented solutions for the pharma supply chain will provide advanced decision-making systems by efficiently collecting and managing data in real-time and generating actionable insights. Beyond these benefits, AI is capable of seeing patterns that even trained professionals might miss. Further, it supplies real-time actionable insights filling the potential knowledge gap between suppliers, drug manufacturers, and logistics providers.

Related case study: Developing a logistics platform offering real-time visibility and integrations with different carriers

One of our clients was seeking to improve the global supply chain management optimization product Our challenge? Providing visibility and data transmission for maximum efficiency and control. We supported solution development for end-to-end execution of logistics activities in Supply Chain Management at the PO/SKU level, including PO creation, stock management, suppliers and distributors management, consolidation and load planning, carrier allocation, documentation, and final delivery. Read more about this case study.

Optimizing pharma inventory management

artificial intelligence for pharma inventory management

Once you have an end-to-end view, you can optimize how the supply chain works, especially when it comes to inventory management. AI aids the decision-making process, like warehouses to stock with inventory according to proximity to their biggest customer bases, tracking warehouse capacity, and required transportation capabilities. Smooth warehousing also means tracking inventory to carry and how to distribute it. When and what to reorder for optimal inventory carry costs and supplier bulk order discounts to keep stock keeping units (SKU) profile and quantities at an optimal level.

Optimize for predictive maintenance

artificial intelligence for predictive maintenance of pharmaceutical supply chain

With full process visibility, one step further can be made on the path towards optimization with predictive analytics and machine learning technology. Using AI to process supply chain data is critical to support real-time decision-making, orchestrating operational efficiency, ultimately creating a cost-effective, near-autonomous, and thriving supply chain. The intelligent supply chain identifies and understands the patterns influencing it rather than projecting past demand. Solutions based on AI are generally better at demand anticipation (SKU, quantities) and characterization (localization, service levels). AI technologies can find patterns and interdependencies between variables that traditional methods would otherwise miss. Leveraging AI through real-time production and distribution monitoring can produce actionable predictions that will optimize maintenance, minimize shortages and bottlenecks and, ultimately, maximize pharmaceutical supply chain efficiency.

Medicine demand forecasting, logistics, and stock management

artificial intelligence for drug distribution and logistics

Digitalization and automation of operations can help businesses from the pharma industry establish cost-effective, reliable, and robust processes coordinated across the pharmaceutical supply chain. Adopting AI tools, such as image recognition and analysis, into distribution platforms will be the key to minimizing human error and leveraging operational data to generate strategic insights and improve productivity and accuracy. This can be optimized by implementing an Internet of Things (IoT) platform, which interconnects digital, physical, and third-party information through the use of chips, cameras, sensors, and networks. IoT connections, therefore, generate a vast amount of monitoring data, which can then be unlocked and optimized by using advanced analytics with AI opportunities.

A popular example of IoT coupled with AI technology would be quality assurance along the production line with interconnected sensorized devices and computer vision systems. Additional sensors that track environmental conditions along the supply chain ensure the pharmaceuticals' development and distribution operations' safety.

Including robotics solutions in the pharmaceutical supply chain helps reach an unprecedented level of automation to increase operation accuracy, repeatability, and throughput, while reducing human errors and improving quality and compliance.

Related case study: Optimizing drug distribution activities to hospital pharmacies network

To improve current large scale procurement processes, a pharma company approached us to use applied analytics to stock and distribute drugs among US hospitals. Our challenge? Maximizing savings by streamlining the procurement of medication across the hospital network and their pharmacies. Read more about this case study.

Smart automation

artificial intelligence for pharma process automation and augmentation

Digitalization and automation of operations can help businesses from the pharma industry establish cost-effective, reliable, and robust processes coordinated across the pharmaceutical supply chain. Adopting AI tools, such as image recognition and analysis, into distribution platforms will be the key to minimizing human error and leveraging operational data to generate strategic insights and improve productivity and accuracy. This can be optimized by implementing an Internet of Things (IoT) platform, which interconnects digital, physical, and third-party information through the use of chips, cameras, sensors, and networks. IoT connections, therefore, generate a vast amount of monitoring data, which can then be unlocked and optimized by using advanced analytics with AI opportunities.

A popular example of IoT coupled with AI technology would be quality assurance along the production line with interconnected sensorized devices and computer vision systems. Additional sensors that track environmental conditions along the supply chain ensure the pharmaceuticals' development and distribution operations' safety.

Including robotics solutions in the pharmaceutical supply chain helps reach an unprecedented level of automation to increase operation accuracy, repeatability, and throughput, while reducing human errors and improving quality and compliance.

A secure process that is resistant to counterfeit

artificial intelligence for drug safety and quality assurance

Medicines contamination is not an option for pharmaceutical companies. If a defective drug gets to a patient, the consequences are catastrophic and, in the worst cases, fatal.

End-user safety is always the main driver for drug manufacturers to ensure product quality, and companies introduce quality assurance processes to comply with regulatory affairs. Combining AI with other advanced technologies, such as mentioned in the previous paragraph, automation, can create a transparent, secure system and shielded from counterfeit and substandard drugs. AI algorithms, based on deep learning or machine learning, can be designed to distinguish between genuine and counterfeit versions of the same drug that can affect patient health.

A digitized and integrated quality and compliance system can be a competitive advantage in terms of quality and safety and costs. Drug manufacturers also want to avoid costly recalls and investigations if the affected medicine gets to market, investigations, and lawsuits that could drag on endlessly for years and continue to rise into huge losses. A manufacturing line that focuses on quality by design brings even more advantages, including reduced waste, minimized risks, and can eliminate errors early on in the drug development process.

Roadmap to support AI adoption in the pharma supply chain

The promise of AI in streamlining the pharma supply chain and delivering the next generation of medicines is clear. However, as is the case with most new technologies, outdated IT infrastructure and skillsets limit its uptake on the ground. To develop these new capabilities, we propose an iterative approach to scope the project and evaluate the Proof of AI Development. This approach allows companies to gain confidence in the models and use them as foundations for new service models supported by new abilities and analytical competencies before moving towards mature AI adoption.

Considarations that support AI adoption in the pharma supply chain

Spot challenges where AI can bring unique value

Before you even start building any model, you have to define upfront how it will be used and why that’s going to make the experience better for your business and patients. For that, we recommend our custom AI Design Sprint workshops, where in just two days, we scope and quickly validate new project ideas. You can read more about this collaborative technique here.

Make sure your data is in order

Ensuring your data house is mature enough is critical. Artificial Intelligence models need a strong pipeline of clean, normalized data to produce quality results. You will need a digitized ecosystem that gathers historical data on suppliers, manufacturing, orders, transportations, etc. If you don’t have normalized data stored, start collecting it now. If you think about future AI development in a specific area, think early about the data needs it is going to produce. It is important to consult your idea with a data scientist to prepare a data collection strategy that will improve your future model’s accuracy and provide better value for your business. Digital transformation and building united data systems also take time, so make sure to plan it.

Start small with Proof of AI and be prepared for failure

Pharma supply chains must be ready for failure. Equally, this is also not a sector where a failure is an option. Testing with agility is key. Therefore, we recommend starting with a minimum viable product (MVP) version of your idea. The Proof of AI, as we call it, guarantees a much-reduced risk of failure, as it only takes a couple of weeks to develop. Still, you can quickly observe what AI brings and decide whether to follow up with further investment, whether you should shift or move forward to define your next key goal.

Hire the right experts' team

Implementing artificial intelligence requires significant investment in terms of both finances and resources. Commonly, pharmaceutical manufacturers and distributors don’t have the skills required to implement AI solutions within their IT personnel. Outsourcing AI implementation efforts to a skilled agency with ML experts on board is much simpler than building an in-house data science team from the ground up without knowing how to do it. Keep in mind that engineers are not your only need. Just as much you need designers and project managers that have solid experience with the specifics of AI products.

Collaborate

Collaboration is vital for an AI technology project to succeed, especially in the SCM sector. Not just between global supply chain partners, but pharmaceutical companies must also pool resources and ideas to ensure the technology reaches its full potential. The healthcare sector has its specifics. Still, there is much to learn for the life sciences industry from other business sectors and their AI applications in SCM. Collaboration for healthcare projects also means cooperation with legal and regulatory departments for safe implementation.

Track and optimize for key metrics

Scale your digital solution, build automated data pipelines, and deploy your artificial intelligence products for real-time usage. Constantly improve by adjusting algorithms to meet your desired benchmarks and KPIs. See how it brings results for your business, and think about the next AI project that will boost the medicine supply chain for more sustainable healthcare industry.

Conclusions

The true value that AI-based software brings to the healthcare industry and various pharmaceutical companies is indisputable. Smart adoption of these emerging technologies for the pharmaceutical supply chains will enhance productivity, reduce waste and cut costs. Pharmaceutical organizations must adopt a proactive strategy to maximize value from prior investments by focusing on digitalization in existing solutions and processes and generating new value by embracing new, improved solutions, systems, and best practices to produce drugs highest standard.

References

PWC Pharma 2020: Supplying the future

Forbes - How Artificial Intelligence Is Improving The Pharma Supply Chain

About the author

Dorota Owczarek

AI Product Lead & Design Thinking Facilitator

With over ten years of professional experience in designing and developing software, Dorota is quick to recognize the best ways to serve users and stakeholders by shaping strategies and ensuring their execution by working closely with engineering and design teams. She acts as a Product Leader, covering the ongoing AI agile development processes and operationalizing AI throughout the business.

Would you like to discuss
AI opportunities in your
business?

Let us know and Patricia
will arrange a call with our experts.

Thanks for the message!

We'll do our best to get back to you
as soon as possible.

This article is a part of

7 / 10 articles

AI in Pharma

The pharmaceutical industry is one of the most regulated industries in the world. It's also one of the most expensive and challenging industries to work in. Pharma companies, like all other businesses, are looking for ways to reduce costs while improving quality and efficiency. This is where artificial intelligence comes into play!

Follow our article series to find out what are the benefits of AI in pharma and why this tech could be considered a game changer for the pharmaceutical sector.

check it out

More articles

Find us on

Need help with implementing AI in your business?

Let's talk blue circle

This site uses cookies for analytical purposes.

Accept Privacy Policy

In the interests of your safety and to implement the principle of lawful, reliable and transparent processing of your personal data when using our services, we developed this document called the Privacy Policy. This document regulates the processing and protection of Users’ personal data in connection with their use of the Website and has been prepared by Nexocode.

To ensure the protection of Users' personal data, Nexocode applies appropriate organizational and technical solutions to prevent privacy breaches. Nexocode implements measures to ensure security at the level which ensures compliance with applicable Polish and European laws such as:

  1. Regulation (EU) 2016/679 of the European Parliament and of the Council of 27 April 2016 on the protection of natural persons with regard to the processing of personal data and on the free movement of such data, and repealing Directive 95/46/EC (General Data Protection Regulation) (published in the Official Journal of the European Union L 119, p 1); Act of 10 May 2018 on personal data protection (published in the Journal of Laws of 2018, item 1000);
  2. Act of 18 July 2002 on providing services by electronic means;
  3. Telecommunications Law of 16 July 2004.

The Website is secured by the SSL protocol, which provides secure data transmission on the Internet.

1. Definitions

  1. User – a person that uses the Website, i.e. a natural person with full legal capacity, a legal person, or an organizational unit which is not a legal person to which specific provisions grant legal capacity.
  2. Nexocode – NEXOCODE sp. z o.o. with its registered office in Kraków, ul. Generała Henryka Kamieńskiego 51, 30-644 Kraków, entered into the Register of Entrepreneurs of the National Court Register kept by the District Court for Kraków-Śródmieście in Kraków, 11th Commercial Department of the National Court Register, under the KRS number: 0000686992, NIP: 6762533324.
  3. Website – website run by Nexocode, at the URL: nexocode.com whose content is available to authorized persons.
  4. Cookies – small files saved by the server on the User's computer, which the server can read when when the website is accessed from the computer.
  5. SSL protocol – a special standard for transmitting data on the Internet which unlike ordinary methods of data transmission encrypts data transmission.
  6. System log – the information that the User's computer transmits to the server which may contain various data (e.g. the user’s IP number), allowing to determine the approximate location where the connection came from.
  7. IP address – individual number which is usually assigned to every computer connected to the Internet. The IP number can be permanently associated with the computer (static) or assigned to a given connection (dynamic).
  8. GDPR – Regulation 2016/679 of the European Parliament and of the Council of 27 April 2016 on the protection of individuals regarding the processing of personal data and onthe free transmission of such data, repealing Directive 95/46 / EC (General Data Protection Regulation).
  9. Personal data – information about an identified or identifiable natural person ("data subject"). An identifiable natural person is a person who can be directly or indirectly identified, in particular on the basis of identifiers such as name, identification number, location data, online identifiers or one or more specific factors determining the physical, physiological, genetic, mental, economic, cultural or social identity of a natural person.
  10. Processing – any operations performed on personal data, such as collecting, recording, storing, developing, modifying, sharing, and deleting, especially when performed in IT systems.

2. Cookies

The Website is secured by the SSL protocol, which provides secure data transmission on the Internet. The Website, in accordance with art. 173 of the Telecommunications Act of 16 July 2004 of the Republic of Poland, uses Cookies, i.e. data, in particular text files, stored on the User's end device.
Cookies are used to:

  1. improve user experience and facilitate navigation on the site;
  2. help to identify returning Users who access the website using the device on which Cookies were saved;
  3. creating statistics which help to understand how the Users use websites, which allows to improve their structure and content;
  4. adjusting the content of the Website pages to specific User’s preferences and optimizing the websites website experience to the each User's individual needs.

Cookies usually contain the name of the website from which they originate, their storage time on the end device and a unique number. On our Website, we use the following types of Cookies:

  • "Session" – cookie files stored on the User's end device until the Uses logs out, leaves the website or turns off the web browser;
  • "Persistent" – cookie files stored on the User's end device for the time specified in the Cookie file parameters or until they are deleted by the User;
  • "Performance" – cookies used specifically for gathering data on how visitors use a website to measure the performance of a website;
  • "Strictly necessary" – essential for browsing the website and using its features, such as accessing secure areas of the site;
  • "Functional" – cookies enabling remembering the settings selected by the User and personalizing the User interface;
  • "First-party" – cookies stored by the Website;
  • "Third-party" – cookies derived from a website other than the Website;
  • "Facebook cookies" – You should read Facebook cookies policy: https://www.facebook.com/policy/cookies
  • "Other Google cookies" – Refer to Google cookie policy: www.google.com/policies/technologies/types/

3. How System Logs work on the Website

User's activity on the Website, including the User’s Personal Data, is recorded in System Logs. The information collected in the Logs is processed primarily for purposes related to the provision of services, i.e. for the purposes of:

  • analytics – to improve the quality of services provided by us as part of the Website and adapt its functionalities to the needs of the Users. The legal basis for processing in this case is the legitimate interest of Nexocode consisting in analyzing Users' activities and their preferences;
  • fraud detection, identification and countering threats to stability and correct operation of the Website.

4. Cookie mechanism on the Website

Our site uses basic cookies that facilitate the use of its resources. Cookies contain useful information and are stored on the User's computer – our server can read them when connecting to this computer again. Most web browsers allow cookies to be stored on the User's end device by default. Each User can change their Cookie settings in the web browser settings menu: Google ChromeOpen the menu (click the three-dot icon in the upper right corner), Settings > Advanced. In the "Privacy and security" section, click the Content Settings button. In the "Cookies and site date" section you can change the following Cookie settings:

  • Deleting cookies,
  • Blocking cookies by default,
  • Default permission for cookies,
  • Saving Cookies and website data by default and clearing them when the browser is closed,
  • Specifying exceptions for Cookies for specific websites or domains

Internet Explorer 6.0 and 7.0
From the browser menu (upper right corner): Tools > Internet Options > Privacy, click the Sites button. Use the slider to set the desired level, confirm the change with the OK button.

Mozilla Firefox
browser menu: Tools > Options > Privacy and security. Activate the “Custom” field. From there, you can check a relevant field to decide whether or not to accept cookies.

Opera
Open the browser’s settings menu: Go to the Advanced section > Site Settings > Cookies and site data. From there, adjust the setting: Allow sites to save and read cookie data

Safari
In the Safari drop-down menu, select Preferences and click the Security icon.From there, select the desired security level in the "Accept cookies" area.

Disabling Cookies in your browser does not deprive you of access to the resources of the Website. Web browsers, by default, allow storing Cookies on the User's end device. Website Users can freely adjust cookie settings. The web browser allows you to delete cookies. It is also possible to automatically block cookies. Detailed information on this subject is provided in the help or documentation of the specific web browser used by the User. The User can decide not to receive Cookies by changing browser settings. However, disabling Cookies necessary for authentication, security or remembering User preferences may impact user experience, or even make the Website unusable.

5. Additional information

External links may be placed on the Website enabling Users to directly reach other website. Also, while using the Website, cookies may also be placed on the User’s device from other entities, in particular from third parties such as Google, in order to enable the use the functionalities of the Website integrated with these third parties. Each of such providers sets out the rules for the use of cookies in their privacy policy, so for security reasons we recommend that you read the privacy policy document before using these pages. We reserve the right to change this privacy policy at any time by publishing an updated version on our Website. After making the change, the privacy policy will be published on the page with a new date. For more information on the conditions of providing services, in particular the rules of using the Website, contracting, as well as the conditions of accessing content and using the Website, please refer to the the Website’s Terms and Conditions.

Nexocode Team